Laurence Lockman

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

Arnaud M. Didierlaurent, Sandra Morel, Laurence Lockman et al. · The Journal of Immunology · 2009 · 742 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice

Najoua Dendouga, Michel Fochesato, Laurence Lockman et al. · Vaccine · 2012 · 149 citations

Life Sciences, Immunology, Infectious Diseases +16

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in<i>Cervarix</i>™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

Michel Deschuyteneer, Abdelatif Elouahabi, Dominique Plainchamp et al. · Human Vaccines · 2010 · 133 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule

Mathieu Boxus, Laurence Lockman, Michel Fochesato et al. · Vaccine · 2014 · 38 citations

Medicine, Immunology, Oncology +17

DNA Microarray to Monitor the Expression of MAGE-A Genes

Nathalie Zammatteo, Laurence Lockman, Francis Brasseur et al. · Clinical Chemistry · 2002 · 33 citations

Life Sciences, Molecular Biology, Oncology +17